| MODERN RESEARCH ON CHINESE MATERIA MEDICA |
|
| Year : 2015 | Volume
: 1
| Issue : 1 | Page : 5-15 |
|
|
The role of the European Pharmacopoeia (Ph Eur) in quality control of traditional Chinese herbal medicine in European member states
Mei Wang1, Gerhard Franz2
1 Sino-Dutch Centre for Preventive and Personalised Medicine/SU BioMedicine, Utrechtseweg 48, 3700AJ Zeist, the Netherlands
2 University of Regensburg Department of Pharmacy, Universitätsstraße 31, 93040 Regensburg, Germany
Correspondence Address:
Gerhard Franz
University of Regensburg Department of Pharmacy, Universitätsstraße 31, 93040 Regensburg
Germany
Mei Wang
Sino-Dutch Centre for Preventive and Personalised Medicine/SU BioMedicine, Utrechtseweg 48, 3700AJ Zeist
the Netherlands
 Source of Support: None, Conflict of Interest: None  | 28 |
DOI: 10.15806/j.issn.2311-8571.2014.0021
|
|
|
In order to assure the safety and efficacy of the Chinese Medicines in Europe, the quality of TCM herbals should be guaranteed so that they can be freely imported in the European Union and other Western European Countries which are signatories of the European Pharmacopoeia Convention. Consequently, new Ph Eur TCM herbal drug Monographs should be elaborated, based on preexisting Monographs in the Chinese Pharmacopoeia (ChP) 2010.
Such a program has been inaugurated in 2005 by the Ph Eur Groups of Experts 13 A and B (Phytochemistry). Since then good progress has been made, elaborating of about one third of the originally proposed 100 TCM herbals being identified as important monographs for the European Market. Taking into account the many challenges still laying ahead, the establishment of a specialized Working Party (WP) on TCM with specialists and experts from many EU Member States has been decided by the Ph Eur Commission in 2008 which is highly active ever since in the examination and elaboration of new TCM herbal drug monographs, primarily to assure the safety of the European patient and further to provide quality parameters extremely important for all registration and licensing procedures of the respective National Authorities all over Europe.
This paper is a survey of results and difficulties obtained so far which has been encountered meanwhile in the elaboration process by the Ph Eur TCM WP of these monographs and will discuss these in detail. Moreover the role of Ph Eur TCM monographs in the European community is addressed.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
